Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.UroTodayBacillus Calmette-Guérin in urothelial carcinoma, high-dose interleukin-2 in renal cell carcinoma, and sipuleucel-T in prostate cancer serve as enduring exam… Continue reading
Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.UroTodayBacillus Calmette-Guérin in urothelial carcinoma, high-dose interleukin-2 in renal cell carcinoma, and sipuleucel-T in prostate cancer serve as enduring exam… Continue reading
Using Immunotherapy for the Treatment of mCRCTargeted OncologyThierry Andre, MD, a professor of medical oncology at the University Pierre et Marie Curie, and Head of the Medical Oncology Department in St. Antoine Hospital, Assistance Publique Hôpitaux … Continue reading
Using Immunotherapy for the Treatment of mCRCTargeted OncologyThierry Andre, MD, a professor of medical oncology at the University Pierre et Marie Curie, and Head of the Medical Oncology Department in St. Antoine Hospital, Assistance Publique Hôpitaux … Continue reading
PLOS Research News |
Cutting Down Malaria with CRISPR: Mosquito gene editing as a new form of transmission prevention
PLOS Research News Mosquitoes aren’t just annoying pests, they’re one of the deadliest animals in the world. Each year mosquitoes transmit fatal diseases to millions of people, including malaria. Malaria kills nearly half a million people worldwide annually, and while … Johns Hopkins scientists genetically engineer malaria-resistant mosquitoesDigital Trends |